202 related articles for article (PubMed ID: 32232430)
1. Somatic SMAD3-activating mutations cause melorheostosis by up-regulating the TGF-β/SMAD pathway.
Kang H; Jha S; Ivovic A; Fratzl-Zelman N; Deng Z; Mitra A; Cabral WA; Hanson EP; Lange E; Cowen EW; Katz J; Roschger P; Klaushofer K; Dale RK; Siegel RM; Bhattacharyya T; Marini JC
J Exp Med; 2020 May; 217(5):. PubMed ID: 32232430
[TBL] [Abstract][Full Text] [Related]
2. Somatic activating mutations in MAP2K1 cause melorheostosis.
Kang H; Jha S; Deng Z; Fratzl-Zelman N; Cabral WA; Ivovic A; Meylan F; Hanson EP; Lange E; Katz J; Roschger P; Klaushofer K; Cowen EW; Siegel RM; Marini JC; Bhattacharyya T
Nat Commun; 2018 Apr; 9(1):1390. PubMed ID: 29643386
[TBL] [Abstract][Full Text] [Related]
3. Hide and seek: Somatic SMAD3 mutations in melorheostosis.
Velchev JD; Verstraeten A; Loeys B
J Exp Med; 2020 May; 217(5):. PubMed ID: 32289153
[TBL] [Abstract][Full Text] [Related]
4. Distinct Clinical and Pathological Features of Melorheostosis Associated With Somatic MAP2K1 Mutations.
Jha S; Fratzl-Zelman N; Roschger P; Papadakis GZ; Cowen EW; Kang H; Lehky TJ; Alter K; Deng Z; Ivovic A; Flynn L; Reynolds JC; Dasgupta A; Miettinen M; Lange E; Katz J; Klaushofer K; Marini JC; Siegel RM; Bhattacharyya T
J Bone Miner Res; 2019 Jan; 34(1):145-156. PubMed ID: 30138550
[TBL] [Abstract][Full Text] [Related]
5. Melorheostosis and Osteopoikilosis: A Review of Clinical Features and Pathogenesis.
Wordsworth P; Chan M
Calcif Tissue Int; 2019 May; 104(5):530-543. PubMed ID: 30989250
[TBL] [Abstract][Full Text] [Related]
6. VEGF Secretion Drives Bone Formation in Classical MAP2K1+ Melorheostosis.
Allbritton-King JD; Maity J; Patel A; Colbert RA; Navid F; Bhattacharyya T
J Bone Miner Res; 2023 Dec; 38(12):1834-1845. PubMed ID: 37737377
[TBL] [Abstract][Full Text] [Related]
7. Melorheostotic Bone Lesions Caused by Somatic Mutations in MAP2K1 Have Deteriorated Microarchitecture and Periosteal Reaction.
Fratzl-Zelman N; Roschger P; Kang H; Jha S; Roschger A; Blouin S; Deng Z; Cabral WA; Ivovic A; Katz J; Siegel RM; Klaushofer K; Fratzl P; Bhattacharyya T; Marini JC
J Bone Miner Res; 2019 May; 34(5):883-895. PubMed ID: 30667555
[TBL] [Abstract][Full Text] [Related]
8. A multi-omics approach expands the mutational spectrum of MAP2K1-related melorheostosis.
De Ridder R; Boudin E; Zillikens MC; Ibrahim J; van der Eerden BCJ; Van Hul W; Mortier G
Bone; 2020 Aug; 137():115406. PubMed ID: 32387835
[TBL] [Abstract][Full Text] [Related]
9. Melorheostosis: a Rare Sclerosing Bone Dysplasia.
Kotwal A; Clarke BL
Curr Osteoporos Rep; 2017 Aug; 15(4):335-342. PubMed ID: 28676968
[TBL] [Abstract][Full Text] [Related]
10. A TGF-beta-inducible cell adhesion molecule, betaig-h3, is downregulated in melorheostosis and involved in osteogenesis.
Kim JE; Kim EH; Han EH; Park RW; Park IH; Jun SH; Kim JC; Young MF; Kim IS
J Cell Biochem; 2000 Mar; 77(2):169-78. PubMed ID: 10723084
[TBL] [Abstract][Full Text] [Related]
11. Clinical characteristics of 10 Chinese patients with melorheostosis and identification of a somatic MAP2K1 variant in one case.
Han X; Xu Y; Wei Z; Wang C; Yue H; Zhang Z
Mol Genet Genomic Med; 2022 Oct; 10(10):e2043. PubMed ID: 36004822
[TBL] [Abstract][Full Text] [Related]
12.
El-Gazzar A; Kang H; Fratzl-Zelman N; Webb E; Barnes AM; Jovanovic M; Mehta SG; Datta V; Saraff V; Dale RK; Rauch F; Marini JC; Högler W
Bone Rep; 2022 Dec; 17():101603. PubMed ID: 35874167
[TBL] [Abstract][Full Text] [Related]
13. Smad3 promotes alkaline phosphatase activity and mineralization of osteoblastic MC3T3-E1 cells.
Sowa H; Kaji H; Yamaguchi T; Sugimoto T; Chihara K
J Bone Miner Res; 2002 Jul; 17(7):1190-9. PubMed ID: 12096832
[TBL] [Abstract][Full Text] [Related]
14. The loss of Smad3 results in a lower rate of bone formation and osteopenia through dysregulation of osteoblast differentiation and apoptosis.
Borton AJ; Frederick JP; Datto MB; Wang XF; Weinstein RS
J Bone Miner Res; 2001 Oct; 16(10):1754-64. PubMed ID: 11585338
[TBL] [Abstract][Full Text] [Related]
15. Small molecule inhibitor of TGF-β signaling enables robust osteogenesis of autologous GMSCs to successfully repair minipig severe maxillofacial bone defects.
Shi A; Heinayati A; Bao D; Liu H; Ding X; Tong X; Wang L; Wang B; Qin H
Stem Cell Res Ther; 2019 Jun; 10(1):172. PubMed ID: 31196174
[TBL] [Abstract][Full Text] [Related]
16. COMP-Ang1, a chimeric form of Angiopoietin 1, enhances BMP2-induced osteoblast differentiation and bone formation.
Jeong BC; Kim HJ; Bae IH; Lee KN; Lee KY; Oh WM; Kim SH; Kang IC; Lee SE; Koh GY; Kim KK; Koh JT
Bone; 2010 Feb; 46(2):479-86. PubMed ID: 19782780
[TBL] [Abstract][Full Text] [Related]
17. Melorheostosis and Osteopoikilosis Clinical and Molecular Description of an Italian Case Series.
Gnoli M; Staals EL; Campanacci L; Bedeschi MF; Faletra F; Gallone S; Gaudio A; Mattina T; Gurrieri F; Percesepe A; Neri I; Virdi A; Tremosini M; Milanesi A; Brizola E; Pedrini E; Sangiorgi L
Calcif Tissue Int; 2019 Aug; 105(2):215-221. PubMed ID: 31129707
[TBL] [Abstract][Full Text] [Related]
18. TGF-β inhibits osteogenesis by upregulating the expression of ubiquitin ligase SMURF1 via MAPK-ERK signaling.
Sun X; Xie Z; Ma Y; Pan X; Wang J; Chen Z; Shi P
J Cell Physiol; 2018 Jan; 233(1):596-606. PubMed ID: 28322449
[TBL] [Abstract][Full Text] [Related]
19. Effects of all-trans retinoic acid on signal pathway of cyclooxygenase-2 and Smad3 in transforming growth factor-β-stimulated glomerular mesangial cells.
Han J; Zhang L; Chen X; Yang B; Guo N; Fan Y
Exp Biol Med (Maywood); 2014 Mar; 239(3):272-83. PubMed ID: 24500985
[TBL] [Abstract][Full Text] [Related]
20. Role of Smad3, acting independently of transforming growth factor-beta, in the early induction of Wnt-beta-catenin signaling by parathyroid hormone in mouse osteoblastic cells.
Inoue Y; Canaff L; Hendy GN; Hisa I; Sugimoto T; Chihara K; Kaji H
J Cell Biochem; 2009 Sep; 108(1):285-94. PubMed ID: 19582775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]